
GNMX ETF: Corgi Genomics & Precision Medicine ETF - Price, Holdings & Analysis
Corgi Genomics & Precision Medicine ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About Corgi Genomics & Precision Medicine ETF
What is the current price of GNMX?
The latest GNMX price is $29.84. The 52-week range is $23.88–$32.31.
What is the expense ratio for GNMX?
GNMX's annual expense ratio is 0.35%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does GNMX pay dividends?
Corgi Genomics & Precision Medicine ETF does not currently pay dividends. Check the ETF Screener for dividend-focused alternatives in the Equity category.
What are the top holdings of GNMX?
GNMX's largest holdings are Thermo Fisher Scientific Inc. (8.6%), Vertex Pharmaceuticals Incorporated (7.0%), Alnylam Pharmaceuticals, Inc. (4.4%) (combined weight: 20.0%). The fund holds 60 total positions. View the complete portfolio breakdown in the Holdings section.
How does GNMX compare to similar ETFs?
Compare GNMX (0.35% expense ratio) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.